JAC Advance Access originally published online on January 23, 2006
Journal of Antimicrobial Chemotherapy 2006 57(3):577; doi:10.1093/jac/dkl001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2006. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Correspondence |
Comment on: Linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus
1 Intensive Care Unit 92, Brugmann University Hospital, Free University of Brussels, Place Van Gehuchten 4, 1020 Brussels, Belgium; 2 Department of Anaesthesiology, Brugmann University Hospital, Free University of Brussels, Place Van Gehuchten 4, 1020 Brussels, Belgium
* Corresponding author. Tel: +32-2-477-92-93; Fax: +32-2-477-92-94; E-mail: david.debels@chu-brugmann.be
Keywords: oxazolidinones , septic shock , toxin , virulence factors
| The first 10% of the full text of this article appears below. |
De Gascun and colleagues report on a case of methicillin-susceptible Staphylococcus aureus (MSSA) sepsis treated successfully with linezolid after initial failure of a triple regimen of apparently appropriate antibiotics.
Transparency declarations